Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $8.94 billion. The enterprise value is $7.51 billion.
| Market Cap | 8.94B |
| Enterprise Value | 7.51B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, before market open.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 83.15 million shares outstanding. The number of shares has increased by 17.71% in one year.
| Current Share Class | 83.15M |
| Shares Outstanding | 83.15M |
| Shares Change (YoY) | +17.71% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 93.38% |
| Float | 66.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 85.15 |
| Forward PS | 296.23 |
| PB Ratio | 5.90 |
| P/TBV Ratio | 5.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 71.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.34, with a Debt / Equity ratio of 0.05.
| Current Ratio | 10.34 |
| Quick Ratio | 9.97 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,036.03 |
Financial Efficiency
Return on equity (ROE) is -24.15% and return on invested capital (ROIC) is -16.37%.
| Return on Equity (ROE) | -24.15% |
| Return on Assets (ROA) | -15.59% |
| Return on Invested Capital (ROIC) | -16.37% |
| Return on Capital Employed (ROCE) | -22.25% |
| Weighted Average Cost of Capital (WACC) | 14.87% |
| Revenue Per Employee | $415,020 |
| Profits Per Employee | -$1.18M |
| Employee Count | 253 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +160.02% in the last 52 weeks. The beta is 1.95, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +160.02% |
| 50-Day Moving Average | 100.49 |
| 200-Day Moving Average | 83.28 |
| Relative Strength Index (RSI) | 51.85 |
| Average Volume (20 Days) | 560,151 |
Short Selling Information
The latest short interest is 9.90 million, so 11.91% of the outstanding shares have been sold short.
| Short Interest | 9.90M |
| Short Previous Month | 10.15M |
| Short % of Shares Out | 11.91% |
| Short % of Float | 14.99% |
| Short Ratio (days to cover) | 7.75 |
Income Statement
In the last 12 months, KYMR had revenue of $105.00 million and -$299.60 million in losses. Loss per share was -$3.21.
| Revenue | 105.00M |
| Gross Profit | -270.57M |
| Operating Income | -346.32M |
| Pretax Income | -299.60M |
| Net Income | -299.60M |
| EBITDA | -341.95M |
| EBIT | -350.18M |
| Loss Per Share | -$3.21 |
Balance Sheet
The company has $690.99 million in cash and $78.56 million in debt, with a net cash position of $1.43 billion or $17.15 per share.
| Cash & Cash Equivalents | 690.99M |
| Total Debt | 78.56M |
| Net Cash | 1.43B |
| Net Cash Per Share | $17.15 |
| Equity (Book Value) | 1.51B |
| Book Value Per Share | 18.23 |
| Working Capital | 665.94M |
Cash Flow
In the last 12 months, operating cash flow was -$236.76 million and capital expenditures -$1.19 million, giving a free cash flow of -$237.96 million.
| Operating Cash Flow | -236.76M |
| Capital Expenditures | -1.19M |
| Depreciation & Amortization | 6.43M |
| Net Borrowing | -1.70M |
| Free Cash Flow | -237.96M |
| FCF Per Share | -$2.86 |
Margins
Gross margin is -257.68%, with operating and profit margins of -329.83% and -285.33%.
| Gross Margin | -257.68% |
| Operating Margin | -329.83% |
| Pretax Margin | -285.33% |
| Profit Margin | -285.33% |
| EBITDA Margin | -325.67% |
| EBIT Margin | -333.51% |
| FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.71% |
| Shareholder Yield | -17.71% |
| Earnings Yield | -3.35% |
| FCF Yield | -2.66% |
Analyst Forecast
The average price target for KYMR is $130.91, which is 21.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $130.91 |
| Price Target Difference | 21.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | 4.99% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 22.57 and a Piotroski F-Score of 4.
| Altman Z-Score | 22.57 |
| Piotroski F-Score | 4 |